Universal Vision Biotechnology Co (大學光學科技), Taiwan’s first biotech firm to list its shares on the GRETAI Securities Market, yesterday signed a pact with a medical university in Fujian Province, paving the way for expansion into China.
“This partnership will help us train the necessary human resources, letting us get ready to move into the mainland market,” chairman Ou Shu-fong (歐淑芳) said on the sidelines of the signing ceremony.
The company yesterday signed a cooperation agreement with Fujian Medical University, beginning an exchange program for medical students and specialists to undergo training in both countries.
Universal Vision has had personnel exchanges with medical schools in Beijing, Shanghai and Guangzhou for the past 10 years, and company officials hope cooperation with Fujian Medical University will broaden the company’s human resources base, enabling it to move into China “in the near term,” Ou said.
She said the company’s expansion plan would be announced by year’s end without revealing the exact timeline.
Universal Vision specializes in ophthalmology, with establishments such as Universal Eye Centers (大學眼科), Universal Beauty Clinics (大學醫學美容) and optometric centers E-feye (大學眼鏡) across the nation.
The company offers a wide range of services from ophthalmology research in stem cells, optical material developments and technology, to eye operation, sales of eye glasses and healthcare products.
Ou said a number of ophthalmology specialists from Europe, the US and Japan have attempted to create footholds in China, but to no avail because of cultural and linguistic barriers.
“Because eye clinics in China are moving toward high-end services, it gives us an opportunity to expand into the market,” she said.
The company will apply its successful business model and bring experts and a wide array of services to Fujian Province, which is its first destination for expansion.
The company is joining forces with Chinese medical centers to nurture personnel in a bid to make sure it has ample specialists, Ou said.
The developing medical industry in China has attracted Taiwanese companies to set up medical facilities over the years. They include Chang Gung Medical Foundation (長庚醫療), which has a presence in Xiamen, BenQ Group (明基集團) in Nanjing and Want Want China Holdings Ltd (旺旺中國控股) in Hunan.
BenQ Group poured 1.1 billion yuan (US$161 million) into the BenQ Hospital in Nanjing in May last year. The group is currently building another hospital in Suzhou.
IN THE AIR: While most companies said they were committed to North American operations, some added that production and costs would depend on the outcome of a US trade probe Leading local contract electronics makers Wistron Corp (緯創), Quanta Computer Inc (廣達), Inventec Corp (英業達) and Compal Electronics Inc (仁寶) are to maintain their North American expansion plans, despite Washington’s 20 percent tariff on Taiwanese goods. Wistron said it has long maintained a presence in the US, while distributing production across Taiwan, North America, Southeast Asia and Europe. The company is in talks with customers to align capacity with their site preferences, a company official told the Taipei Times by telephone on Friday. The company is still in talks with clients over who would bear the tariff costs, with the outcome pending further
NEGOTIATIONS: Semiconductors play an outsized role in Taiwan’s industrial and economic development and are a major driver of the Taiwan-US trade imbalance With US President Donald Trump threatening to impose tariffs on semiconductors, Taiwan is expected to face a significant challenge, as information and communications technology (ICT) products account for more than 70 percent of its exports to the US, Chung-Hua Institution for Economic Research (CIER, 中華經濟研究院) president Lien Hsien-ming (連賢明) said on Friday. Compared with other countries, semiconductors play a disproportionately large role in Taiwan’s industrial and economic development, Lien said. As the sixth-largest contributor to the US trade deficit, Taiwan recorded a US$73.9 billion trade surplus with the US last year — up from US$47.8 billion in 2023 — driven by strong
A proposed 100 percent tariff on chip imports announced by US President Donald Trump could shift more of Taiwan’s semiconductor production overseas, a Taiwan Institute of Economic Research (TIER) researcher said yesterday. Trump’s tariff policy will accelerate the global semiconductor industry’s pace to establish roots in the US, leading to higher supply chain costs and ultimately raising prices of consumer electronics and creating uncertainty for future market demand, Arisa Liu (劉佩真) at the institute’s Taiwan Industry Economics Database said in a telephone interview. Trump’s move signals his intention to "restore the glory of the US semiconductor industry," Liu noted, saying that
AI: Softbank’s stake increases in Nvidia and TSMC reflect Masayoshi Son’s effort to gain a foothold in key nodes of the AI value chain, from chip design to data infrastructure Softbank Group Corp is building up stakes in Nvidia Corp and Taiwan Semiconductor Manufacturing Co (TSMC, 台積電), the latest reflection of founder Masayoshi Son’s focus on the tools and hardware underpinning artificial intelligence (AI). The Japanese technology investor raised its stake in Nvidia to about US$3 billion by the end of March, up from US$1 billion in the prior quarter, regulatory filings showed. It bought about US$330 million worth of TSMC shares and US$170 million in Oracle Corp, they showed. Softbank’s signature Vision Fund has also monetized almost US$2 billion of public and private assets in the first half of this year,
RSS